Blueprint Medicines to Report Second Quarter 2020 Financial Results on Thursday, July 30, 2020

Blueprint Medicines Corporation (NASDAQ: BPMC) will host a live conference call on July 30, 2020, at 8:30 a.m. ET to discuss its second quarter 2020 financial results and provide a corporate update.

Rhea-AI Summary

Blueprint Medicines Corporation (NASDAQ: BPMC) will host a live conference call on July 30, 2020, at 8:30 a.m. ET to discuss its second quarter 2020 financial results and provide a corporate update. Investors can join the call by dialing (855) 728-4793 for domestic calls or (503) 343-6666 for international calls, using conference ID 2769677. A webcast will also be available on their website and archived for 30 days afterward.

Argus Session date unavailable

-3.11% session move Open Argus

Details

News Market Reaction – BPMC

The recorded move for BPMC in the trading session of this news was -3.11%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., July 23, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, July 30, 2020 to report its second quarter 2020 financial results and provide a corporate update.

To access the live conference call, please dial (855) 728-4793 (domestic) or (503) 343-6666 (international), and refer to conference ID 2769677. A webcast of the call will also be available under "Events and Presentations" in the Investors & Media section of the Blueprint Medicines website at http://ir.blueprintmedicines.com/. The archived webcast will be available on Blueprint Medicines' website approximately two hours after the conference call and will be available for 30 days following the call.

About Blueprint Medicines

Blueprint Medicines is a precision therapy company striving to improve human health. With a focus on genomically defined cancers, rare diseases and cancer immunotherapy, we are developing transformational medicines rooted in our leading expertise in protein kinases, which are proven drivers of disease. Our uniquely targeted, scalable approach empowers the rapid design and development of new treatments and increases the likelihood of clinical success. We have one FDA-approved precision therapy and are currently advancing multiple investigational medicines in clinical development, along with a number of research programs. For more information, visit www.BlueprintMedicines.com and follow us on Twitter (@BlueprintMeds) and LinkedIn.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/blueprint-medicines-to-report-second-quarter-2020-financial-results-on-thursday-july-30-2020-301098587.html

SOURCE Blueprint Medicines Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Blueprint Medicines report its second quarter 2020 financial results?

Blueprint Medicines will report its second quarter 2020 financial results on July 30, 2020.

How can I access the Blueprint Medicines conference call?

You can access the conference call by dialing (855) 728-4793 domestically or (503) 343-6666 internationally, using conference ID 2769677.

Will there be a webcast of the Blueprint Medicines conference call?

Yes, a webcast of the conference call will be available on the Blueprint Medicines website under 'Events and Presentations'.

How long will the archived webcast of the conference call be available?

The archived webcast will be available for 30 days after the call.